ub.xmlui.mirage2.page-structure.muninLogoub.xmlui.mirage2.page-structure.openResearchArchiveLogo
    • EnglishEnglish
    • norsknorsk
  • Velg spraaknorsk 
    • EnglishEnglish
    • norsknorsk
  • Administrasjon/UB
Vis innførsel 
  •   Hjem
  • Det helsevitenskapelige fakultet
  • Institutt for samfunnsmedisin
  • Artikler, rapporter og annet (samfunnsmedisin)
  • Vis innførsel
  •   Hjem
  • Det helsevitenskapelige fakultet
  • Institutt for samfunnsmedisin
  • Artikler, rapporter og annet (samfunnsmedisin)
  • Vis innførsel
JavaScript is disabled for your browser. Some features of this site may not work without it.

Psychological effect of cervical cancer screening when changing primary screening method from cytology to high-risk human papilloma virus testing

Permanent lenke
https://hdl.handle.net/10037/17750
DOI
https://doi.org/10.1002/ijc.32067
Thumbnail
Åpne
article.pdf (2.671Mb)
Publisert versjon (PDF)
Dato
2018-12-14
Type
Journal article
Tidsskriftartikkel
Peer reviewed

Forfatter
Andreassen, Trude; Hansen, Bo Terning; Engesæter, Birgit Øvstebø; Hashim, Dana; Støer, Nathalie Charlotte; Trope, Ameli; Moen, Kåre; Ursin, Giske; Weiderpass, Elisabete
Sammendrag
From 2015, Norway has implemented high‐risk human papilloma virus (hrHPV) testing in primary screening for cervical cancer. Women aged 34–69 years, living in four counties, have been pseudo‐randomly assigned (1:1 randomization) to either hrHPV testing every 5 years (followed by cytology if hrHPV is positive), or cytology testing every 3 years (followed by hrHPV testing if low‐grade cytology is detected). We compared anxiety and depression scores among participants by screening arm and results. In total, 1,008 women answered a structured questionnaire that included the validated Patient Health Questionnaire‐4 (PHQ‐4). The Relative Risk Ratio (RRR) of mild vs. normal anxiety and depression scores, and moderate/severe vs. normal anxiety and depression scores, were estimated by multinomial logistic regression with 95% confidence intervals (95% CIs). Compared to women who were screened with cytology, women randomized to hrHPV testing were not more likely to have mild anxiety and depression scores (RRR 0.96, CI 0.70–1.31) nor more likely to have moderate/severe anxiety and depression scores (RRR 1.14, CI 0.65–2.02). Women with five different combinations of abnormal screening test results were not more likely to have mild or moderate/severe vs. normal anxiety and depression scores than women with normal screening results. The likelihood of having abnormal long‐term (4–24 months after the screening) anxiety or depression scores among women 34 years and older was not affected by screening method or screening results. The results of our study suggest that a change to hrHPV testing in primary screening would not increase psychological distress among participants.
Forlag
Wiley
Sitering
Andreassen T, Hansen BT, Engesæter BØ, Hashim D, Støer N, Trope AEC, Moen K, Ursin G, Weiderpass E. Psychological effect of cervical cancer screening when changing primary screening method from cytology to high-risk human papilloma virus testing. International Journal of Cancer. 2019;145(1):29-39
Metadata
Vis full innførsel
Samlinger
  • Artikler, rapporter og annet (samfunnsmedisin) [1515]
Copyright 2019 The Author(s)

Bla

Bla i hele MuninEnheter og samlingerForfatterlisteTittelDatoBla i denne samlingenForfatterlisteTittelDato
Logg inn

Statistikk

Antall visninger
UiT

Munin bygger på DSpace

UiT Norges Arktiske Universitet
Universitetsbiblioteket
uit.no/ub - munin@ub.uit.no

Tilgjengelighetserklæring